Hjem › Småcellet lungekreft › Indiana › Indianapolis
Kliniske studier for Småcellet lungekreft i Indianapolis, IN
9 studier for Småcellet lungekreft søker deltakere på steder i og rundt Indianapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RekruttererFase 3
- Franciscan St. Francis Health /ID# 279788, Indianapolis
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RekruttererFase 1/2
- Indiana University (IU) Health - Multi-D Oncology Clinic, Indianapolis
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RekruttererFase 2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
RekruttererObservasjonsstudie
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Roudebush VA Medical Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- Community Health Network, Indianapolis
Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer
RekruttererFase 1/2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
RekruttererFase 2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
RekruttererFase 2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
RekruttererFase 1/2
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Småcellet lungekreft-studier i andre byer
- Houston, TX26 studier
- Arlington, VA23 studier
- New York City, NY22 studier
- Boston, MA21 studier
- Nashville, TN20 studier
- Los Angeles, CA20 studier
- Orlando, FL15 studier
- Dallas, TX13 studier
- Cleveland, OH13 studier
- Chicago, IL13 studier
- St. Louis, MO13 studier
- Detroit, MI12 studier
Andre studier i Indianapolis
- Ikke-småcellet lungekreft32 studier
- Kreft (alle typer)24 studier
- Hjertesvikt23 studier
- Fedme20 studier
- Brystkreft20 studier
- Metastatisk kreft19 studier
- Kolorektal kreft18 studier
- Eggstokkreft17 studier
- Kardiovaskulær sykdom17 studier
- Lungekreft16 studier
- Type 1-diabetes14 studier
- Endometriekreft14 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.